We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A Massachusetts U.S. District Court judge has dismissed ex-Pfizer marketing vice president Peter Rost's whistle-blowing case against his former employers, Pharmacia and Pfizer.
The risk of skin rashes and other serious skin reactions seen with an Oscient Pharmaceuticals Corp. (OSCI) antibiotic outweighs possible benefits of using the drug to treat sinus infections, the Food and Drug Administration said Monday.
Genentech Inc. shares lost almost 5% Monday after the Food and Drug Administration said it needs more information to consider approving the biotechnology company's oncology drug Avastin as a treatment for advanced breast cancer.
Costa Mesa, California-based Valeant Pharmaceutical International on Monday morning announced that the Securities and Exchange Commission or SEC is conducting an informal inquiry on the events and circumstances surrounding trading of its common stock and the public release of data from its first pivotal Phase 3 trial for Viramidine, a prodrug of ribavirin for the treatment of chronic hepatitis C.
U.S. prosecutors have joined a whistle-blower lawsuit accusing a subsidiary of German pharmaceutical company Merck KGaA of fraudulently overcharging the Medicare program, the U.S. government said on Monday.
At the FDA's request, U.S. marshals Sept. 5 seized approximately $55,000 of dietary supplements for violating the Federal Food, Drug, and Cosmetic Act's new drug and misbranding provisions.
While Merck is fighting thousands of lawsuits filed by former patients who claim its pain drug Vioxx causes heart attack and stroke, a study has found that Celebrex, a pain drug made by Pfizer that belongs to the same class of drugs as Vioxx, may slow or prevent the onset of colon cancer.
In the latest step in the fight between the FDA and Congress over the agency's handling of sanofi-aventis' antibiotic Ketek, a bipartisan coalition of lawmakers is asking the Government Accountability Office (GAO) to investigate the agency's use of a type of clinical trial associated with the drug.